Last reviewed · How we verify
NCT06360991
DBS for Treatment-resistant Obsessive-compulsive Disorder
NA trial testing Deep brain stimulation (DBS) in Obsessive-Compulsive Disorder (OCD) in 60 participants. Not yet recruiting.
31 December 2028
Quick facts
| Lead sponsor | Xuanwu Hospital, Beijing |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 20 April 2024 |
| Primary completion | 31 December 2028 |
| Estimated completion | 31 December 2029 |
| Sites | 1 location across China |
Drugs / interventions tested
- Deep brain stimulation (DBS)
Conditions studied
- Obsessive-Compulsive Disorder (OCD) — all drugs for Obsessive-Compulsive Disorder (OCD) →
Sponsor
Xuanwu Hospital, Beijing
Who can join
Adults 18 to 65, any sex, with Obsessive-Compulsive Disorder (OCD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary purpose of this study is to investigate the effect of deep brain stimulation (DBS) implantation targeting the anteromedial region of subthalamic nucleus (amSTN), or nucleus accumbens (NAc), or bed nucleus of the stria terminalis (BNST), or ventral capsule/ventral striatum (VC/VS), or the ventral anterior limb of the internal capsule (vALIC) in patients with treatment-resistant obsessive-compulsive disorder (TR-OCD).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06360991
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Deep brain stimulation (DBS)
Trials testing the same drug.
- NCT04568681 — Deep Brain Stimulation Effects in Dystonia · completed
- NCT03605316 — Deep Electrical Neuromodulation in Obsessive-compulsive Disorder · completed
Other recruiting trials for Obsessive-Compulsive Disorder (OCD)
Currently open trials in the same condition.
- NCT07587112 — Explore Neural Mechanism of OCD by Intervention of Repetitive Transcranial Magnetic Stimulation With Symptom Provocation · NA · recruiting
- NCT06647589 — Acceptance and Commitment Therapy for Religious OCD · NA · recruiting
- NCT06782867 — RNS for Treatment-resistant Obsessive-compulsive Disorder · NA · recruiting
- NCT06944366 — Comparing Exposure v Imagery Rescripting in People With OCD: a SCED · NA · recruiting
- NCT02773082 — DBS for Obsessive-Compulsive Disorder · NA · recruiting
Other Xuanwu Hospital, Beijing trials
Trials by the same sponsor.
- NCT07095933 — The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy · EARLY_PHASE1 · recruiting
- NCT07519044 — Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion · Phase 4 · not yet recruiting
- NCT07396077 — Pre-operative Risk Assessment Combined With Targeted Intervention in the Chinese Elderly With Spine Surgery II · NA · not yet recruiting
- NCT07457125 — The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease · Phase 1, PHASE2 · not yet recruiting
- NCT07479446 — Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06360991 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xuanwu Hospital, Beijing
- Last refreshed: 11 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06360991.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing